AU2003214522A1 - Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor - Google Patents

Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor

Info

Publication number
AU2003214522A1
AU2003214522A1 AU2003214522A AU2003214522A AU2003214522A1 AU 2003214522 A1 AU2003214522 A1 AU 2003214522A1 AU 2003214522 A AU2003214522 A AU 2003214522A AU 2003214522 A AU2003214522 A AU 2003214522A AU 2003214522 A1 AU2003214522 A1 AU 2003214522A1
Authority
AU
Australia
Prior art keywords
lcatalbumin
cofactor
variant
alpha
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003214522A
Other languages
English (en)
Other versions
AU2003214522A8 (en
Inventor
Catharina Svanborg
Malin Wilhelmina Svensson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003214522A1 publication Critical patent/AU2003214522A1/en
Publication of AU2003214522A8 publication Critical patent/AU2003214522A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003214522A 2002-03-07 2003-03-07 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor Abandoned AU2003214522A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0205347.8A GB0205347D0 (en) 2002-03-07 2002-03-07 Biologically active complex
GB0205347.8 2002-03-07
PCT/IB2003/001293 WO2003074547A2 (en) 2002-03-07 2003-03-07 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor

Publications (2)

Publication Number Publication Date
AU2003214522A1 true AU2003214522A1 (en) 2003-09-16
AU2003214522A8 AU2003214522A8 (en) 2003-09-16

Family

ID=9932477

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003214522A Abandoned AU2003214522A1 (en) 2002-03-07 2003-03-07 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor

Country Status (6)

Country Link
US (1) US20050085416A1 (enExample)
EP (1) EP1485413A2 (enExample)
JP (1) JP2005530703A (enExample)
AU (1) AU2003214522A1 (enExample)
GB (1) GB0205347D0 (enExample)
WO (1) WO2003074547A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
EP1727561A1 (en) * 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
JP5679992B2 (ja) 2009-01-09 2015-03-04 ハムレット・ファルマ・アーベー 複合体および生産方法
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
ES2613986T3 (es) 2010-11-24 2017-05-29 Hamlet Pharma Ab Complejo biológicamente activo y su preparación
PL2882446T3 (pl) 2012-08-09 2018-10-31 Hamlet Pharma Ab Terapia profilaktyczna i nutraceutyczna
WO2016133991A1 (en) 2015-02-17 2016-08-25 Xylem Ip Uk Sarl Technique for temperature controlling polarimeter sample cells
IT201700104446A1 (it) * 2017-09-19 2019-03-19 Lo Li Pharma Srl Compositions, uses and methods for treatment of infertility and subfertility

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053185B1 (en) * 1997-11-21 2006-05-30 Hamlet Pharma Ab Lactalbumin production process

Also Published As

Publication number Publication date
JP2005530703A (ja) 2005-10-13
WO2003074547A2 (en) 2003-09-12
EP1485413A2 (en) 2004-12-15
GB0205347D0 (en) 2002-04-24
AU2003214522A8 (en) 2003-09-16
WO2003074547A3 (en) 2003-11-27
US20050085416A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
AU2003286867A1 (en) E.x.o. rimwear
AU2003301947A1 (en) Bearing structure
AU2003234635A1 (en) Carpet constructions, systems, and methods
AU2003285952A1 (en) Pyrrolidones with anti-hiv activity
AU2003290685A1 (en) Active fasteners
AU2003299344A1 (en) Game mobile element, such as a game piece, and related game system
AU2003280813A1 (en) Active antenna
AU2003213997A1 (en) Biologically active copper-organic agents
AU2003214522A1 (en) Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
AU2003259455A1 (en) Active display
AU2003274016A1 (en) Spherical bearing
AU2003285258A1 (en) Biologically active peptide conjugates
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2002343197A1 (en) Biologically active complex
AU2003272302A1 (en) A microbial oxidoreductase
AU2003215189A1 (en) Endothelial precursor cells for enhancing and restoring vascular function
AU2002309422A1 (en) Active load arrangement
AU2003224331A1 (en) Insecticides and arachnicides
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2003253511A1 (en) Covering construction, and support beam therefor
AU2003235559A1 (en) Biologically active composition
AU2003216442A1 (en) Enkurin and uses thereof
AU2003216919A1 (en) Antimicrobial active carbon
AU2001262084A1 (en) Maurocalcine, analogues thereof and their therapeutical uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase